Skip to main content

Table 2 Influence of patient characteristics and region on Periprosthetic Joint Infection (PJI) rate

From: Variation in Prosthetic Joint Infection and treatment strategies during 4.5 years of follow-up after primary joint arthroplasty using administrative data of 41397 patients across Australian, European and United States hospitals

Variable Odds Ratio [95% CI]
Age > =70 years 0.75 [0.63-0.89]
Sex (Males versus Females) 1.38 [1.17–1.63]
Comorbidities
 Cardiac arrhythmias (yes/no) 1.32 [0.99–1.74]
 Congestive heart failure (yes/no) 1.58 [0.98–2.53]
 Rheumatoid arthritis, collagen or vascular disease (yes/no) 1.96 [1.39–2.75]
 Diabetes uncomplicated (yes/no) 1.28 [1.00–1.64]
 Coagulopathy (yes/no) 2.28 [1.29–4.03]
 Fluid and electrolyte disorders (yes/no) 1.63 [1.15–2.30]
 Depression (yes/no) 2.04 [1.46–2.86]
Joint (knee versus hip) 1.52 [1.28–1.79]
Region
 Australia versus US 1.40 [1.03–1.91]
 Europe versus US 1.24 [1.01–1.52]
  1. Significant differences are indicated in bold; Model fit: C statistic = 0,61 Nagelkerke R 2 = 0,018